← Back to Search

Mobile App for Suicide Prevention

N/A
Waitlist Available
Research Sponsored by Butler Hospital
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Between the ages of 18 and 26
Be between 18 and 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 1 month
Awards & highlights

Study Summary

This trial will test a new suicide prevention app to see if it's safe and effective.

Who is the study for?
This trial is for young adults aged 18-26 who are comfortable with smartphones and have experienced suicidal thoughts or behaviors in the past month. They must be stable as per their treatment team and proficient in English. Those with severe psychotic or manic symptoms that could disrupt participation cannot join.Check my eligibility
What is being tested?
The study tests a new mobile app called MAPS designed to prevent suicide, comparing it against standard care plus regular self-reports of mood and behavior (TAU + EMA). It aims to see if MAPS is feasible, acceptable, safe, and can reduce suicidal thoughts or re-hospitalization.See study design
What are the potential side effects?
Since this trial involves a mobile application rather than medication, traditional side effects are not expected. However, participants may experience emotional discomfort while discussing sensitive topics like suicide during assessments.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am between 18 and 26 years old.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~1 month
This trial's timeline: 3 weeks for screening, Varies for treatment, and 1 month for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Acceptability of MAPS Intervention
Acceptability of Research (Recruitment)
Acceptability of Research Procedures
+3 more
Secondary outcome measures
Rehospitalization
Suicidal Ideation and Behavior

Trial Design

1Treatment groups
Experimental Treatment
Group I: Mobile Application to Prevent Suicide (MAPS)Experimental Treatment2 Interventions
Participants receiving MAPS will receive the Safety Planning Intervention (SPI) which will be uploaded into the smartphone app. They will be prompted four times per day to complete a brief ecological momentary assessment "check-in" inquiring about their cognitions, affect, and behavior, including suicidal thoughts and behaviors. Based on these responses, they will be provided with coping strategies from their safety plans and from a database of coping strategies created by study staff. They will also have access to emergency phone numbers, the coping strategies database, and can communicate with their study clinician through a text-like interface in the app. They will receive this intervention for one month.

Find a Location

Who is running the clinical trial?

Butler HospitalLead Sponsor
129 Previous Clinical Trials
16,408 Total Patients Enrolled
11 Trials studying Suicide
651 Patients Enrolled for Suicide
American Foundation for Suicide Prevention (AFSP)UNKNOWN
1 Previous Clinical Trials
10 Total Patients Enrolled
1 Trials studying Suicide
10 Patients Enrolled for Suicide

Media Library

Mobile Application to Prevent Suicide (MAPS) Clinical Trial Eligibility Overview. Trial Name: NCT05180344 — N/A
Suicide Research Study Groups: Mobile Application to Prevent Suicide (MAPS)
Suicide Clinical Trial 2023: Mobile Application to Prevent Suicide (MAPS) Highlights & Side Effects. Trial Name: NCT05180344 — N/A
Mobile Application to Prevent Suicide (MAPS) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05180344 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Do individuals of a younger age meet the eligibility requirements for this experiment?

"Prerequisites for entry into this trial necessitates that participants are within the 18-26 age range. There is a separate 84 study selection process for those below 18 and 156 studies available to individuals over 65 years of age."

Answered by AI

Who should consider participating in this research study?

"This investigation requires 40 participants between 18 to 26 years old with a history of suicidal ideation. To be eligible, they need to be sufficiently stable for study participation, at the specified age range and conversant in smartphone technology."

Answered by AI

Are there currently vacancies for participants in this clinical research?

"Per the information on clinicaltrials.gov, this experiment is no longer accepting candidates. Initially posted in October of 2022 and concluding on August 19th 2022, it has since concluded its recruiting phase. However, there remain 244 other trials currently enrolling participants."

Answered by AI
~7 spots leftby May 2024